PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

It’s the first FDA approved trifocal lens implant to correct vision in three ways. It’s called PanOptix. Ophthalmologist Dr. Jeffery Horn of Vision for Life in Nashville was part of the clinical study ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

Please provide your email address to receive an email when new articles are posted on . PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

SCOTTSDALE, Ariz., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Horizon Eye Specialists & Lasik Center, the leading comprehensive eye care center in Arizona, today announces it has started offering the latest ...

Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Patients who received the newly approved PanOptix trifocal lens reported high levels of ...

Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix ...

Novartis International AG / Novartis International AG: Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery . Processed and ...

Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens ...

The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...